Proprio

Proprio, formerly eLoupes, is a leading surgical technology company modernizing the way we predict, perform, and perfect surgery.

Proprio's goal is to significantly improve patient outcomes and surgeon wellbeing through the collaboration of physician expertise and immersive, intelligent technology.

Proprio Vision was co-founded in 2016 by Gabriel Jones, Samuel Browd, James Youngquist, Joshua Smith and Kenneth Denman. The company is headquartered in Seattle, Washington.

 

Proprio's flagship surgical navigation platform, Paradigm™ uses advancements in light field computer vision and AI to synthesize data from multiple inputs for navigating anatomy and surgical environments in 3D. Paradigm provides surgeons with Volumetric Intelligence™, which uniquely combines medical images with live data from Paradigm’s sensor suite.

 

Proprio’s live, 3D, multi-modal data represents a significant upgrade over current static approaches to surgical navigation and the company plans to apply its technology to many surgical specialties beyond its first targets in spine procedures.

 

Proprio’s Paradigm system is capable of collecting a tremendous amount of surgical data that can be utilized for the development of many applications beyond status quo approaches to surgery. Proprio works closely with industry-leading medical and technical advisors and reputable research institutions, including Intel, HTC, Seattle Children’s and University of Washington Medicine.

 

Proprio is backed by DCVC, Intel, Cota Capital, BOLD Capital Partners, HTC, Bird B. AG, Alan Frazier, and others. The company raised $43M in a Series B round on Jul 27, 2023. This brings Proprio's total funding to $73M to date.

 

 

  • Year founded: 2016
  • Funding Info: $73M over 3 Rounds (Latest Funding Type: Series B)
  • Yearly Revenue: NA
  • Employee Size: 51-200
  • Business Valuation: NA
  • City/Town: Seattle
  • State: Washington
  • Country: United States
Related businesses